IN THE NEWS: A new study led by UC Irvine researchers found that while optical coherence tomography (OCT) could potentially guide port-wine birthmark treatment, the technology has a long way to go before it can be used in patient care. Port-wine birthmarks are reddish-purple skin discolorations caused by a concentration…
A false-positive mammogram may deter women from future screenings, according to a new study. But staying on schedule remains key to early detection of cancer.
The Transplant Center is celebrating the one-year anniversary of completing its first liver transplant. During this first year, the center performed a higher-than-expected 41 liver transplants.
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.
A new video-based symptom assessment system for Parkinson’s Disease that is enabled by machine learning represents a potential solution to the challenge of assessing Parkinson’s Disease progression in a quantifiable way.
IN THE NEWS: The UCI Health Kidney Transplant Program, the oldest and largest program in Orange County, recently reached a remarkable milestone on Feb. 7 when it transplanted the 200th kidney into a grateful recipient. Patients, their loved ones and UCI Health co-workers gathered on Aug. 28 to celebrate. Transplant…
IN THE NEWS: As chief procurement officer at UCI Health, Susanna Rustad aligns innovations with the clinical needs of the academic health system for the benefit of patients. Rustad’s work has been recognized by Becker’s Hospital Review, which named her of one of the 2024 supply chain leaders to know…
IN THE NEWS: While ketamine is an effective therapy for treatment-resistant depression, it carries the potential to become addictive. It can even be fatal; actor Matthew Perry died of an overdose of the drug in October 2023. UCI Health psychiatrist Dr. Robert McCarron spoke to the Los Angeles Times about…
